Spotlight
Money Desk
Obituaries
Classifieds
Families First
News
Weather
Specialists
Sports
Business
Opinion
Consumer
Health
Life
Out & About
Login
Weather
6 NC counties are under alert, including Johnston County.
Program
Thursday at 6 on WRAL: School bus safety: After years of mechanical issues, including fires â whatâs being done this year to prevent a disaster?
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
Gold
Crude Oil
Local Stocks
WRALTechWire 30
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by 23andMe, Inc.
23andMe Reports First Quarter Fiscal 2025 Financial Results
August 08, 2024
From
23andMe, Inc.
Via
GlobeNewswire
Tickers
ME
23andMe Special Committee responds to CEO’s take-private proposal
August 02, 2024
From
23andMe, Inc.
Via
GlobeNewswire
Tickers
ME
23andMe Announces CEO’s Take-Private Proposal
August 01, 2024
From
23andMe, Inc.
Via
GlobeNewswire
Tickers
ME
23andMe to Report Q1 FY2025 Financial Results
July 25, 2024
From
23andMe, Inc.
Via
GlobeNewswire
Tickers
ME
Twenty Lung Cancer Advocacy Organizations and 23andMe Come Together to Launch Lung Cancer Genetics Study to Help Advance Research
July 25, 2024
From
23andMe, Inc.
Via
GlobeNewswire
Tickers
ME
23andMe And Nightingale Health Announce Strategic Collaboration To Pilot Blood Biomarker Panel
June 28, 2024
From
23andMe, Inc.
Via
GlobeNewswire
Tickers
ME
23andMe Launches New Genetic Report on Bipolar Disorder
June 05, 2024
From
23andMe, Inc.
Via
GlobeNewswire
Tickers
ME
23andMe and the Colorectal Cancer Alliance Collaborate to Help Advance Colorectal Cancer Research in the Black Community
June 04, 2024
From
23andMe, Inc.
Via
GlobeNewswire
Tickers
ME
23andMe Therapeutics Announces Positive Preliminary Phase 2 Safety and Efficacy Results for 23ME-00610, targeting CD200R1, at the 2024 ASCO Annual Meeting
June 03, 2024
From
23andMe, Inc.
Via
GlobeNewswire
Tickers
ME
Largest study on the LRRK2 variant leads to discoveries about health, ancestry, and history
May 29, 2024
From
23andMe, Inc.
Via
GlobeNewswire
Tickers
ME
23andMe Reports Fourth Quarter and Full Year Fiscal 2024 Financial Results
May 23, 2024
From
23andMe, Inc.
Via
GlobeNewswire
Tickers
ME
Lemonaid Health Now Offers Prescription ED Medication STENDRAⓇ Through Collaboration with Petros Pharmaceuticals
May 14, 2024
From
23andMe, Inc.
Via
GlobeNewswire
Tickers
ME
PTPI
23andMe to Report Q4 and Full Year FY2024 Financial Results
May 09, 2024
From
23andMe, Inc.
Via
GlobeNewswire
Tickers
ME
23andMe to Present Preliminary Efficacy and Biomarker Data for 23ME-00610 at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
April 24, 2024
From
23andMe, Inc.
Via
GlobeNewswire
Tickers
ME
23andMe announces CEO’s intention to pursue a potential take-private
April 18, 2024
From
23andMe, Inc.
Via
GlobeNewswire
Tickers
ME
23andMe to Present Data on Two Clinical Stage Immuno-Oncology Programs at the American Association for Cancer Research (AACR) Annual Meeting 2024
April 05, 2024
From
23andMe, Inc.
Via
GlobeNewswire
Tickers
ME
23andMe Initiates Phase 1 Clinical Trial for its Dual Mechanism Antibody, 23ME-01473, Targeting ULBP6
March 20, 2024
From
23andMe, Inc.
Via
GlobeNewswire
Tickers
ME
23andMe Launches New Feature Connecting Customers to Historical Individuals from Hundreds and Even Thousands of Years Ago
March 19, 2024
From
23andMe, Inc.
Via
GlobeNewswire
Tickers
ME
23andMe Launches New Genetic Reports on Common Forms of Cancer
March 06, 2024
From
23andMe, Inc.
Via
GlobeNewswire
Tickers
ME
23andMe Announces Three Presentations from Clinical-Stage Immuno-Oncology Programs at the American Association for Cancer Research (AACR) Annual Meeting 2024
March 05, 2024
From
23andMe, Inc.
Via
GlobeNewswire
Tickers
ME
23andMe Reports Third Quarter Fiscal 2024 Financial Results
February 07, 2024
From
23andMe, Inc.
Via
GlobeNewswire
Tickers
GSK
ME
23andMe Announces FDA Clearance of IND Application for its Dual Mechanism Antibody, 23ME-01473, Targeting ULBP6
January 31, 2024
From
23andMe, Inc.
Via
GlobeNewswire
Tickers
ME
23andMe Launches Month-Long Initiative to Amplify ARRAY’s “Seat16” Program for Acclaimed Film ORIGIN by Ava DuVernay
January 30, 2024
From
23andMe, Inc.
Via
GlobeNewswire
Tickers
ME
23andMe to Report FY2024 Third Quarter Financial Results
January 24, 2024
From
23andMe, Inc.
Via
GlobeNewswire
Tickers
ME
23andMe announces further expansion of 23ME-00610 Phase 1/2a clinical trial in advanced neuroendocrine and ovarian cancer patient cohorts
December 19, 2023
From
23andMe, Inc.
Via
GlobeNewswire
Tickers
ME
23andMe Reports Second Quarter Fiscal 2024 Financial Results
November 08, 2023
From
23andMe, Inc.
Via
GlobeNewswire
Tickers
ME
23andMe Launches Total Health™, its Comprehensive, Prevention-Based Health Membership
November 07, 2023
From
23andMe, Inc.
Via
GlobeNewswire
Tickers
ME
23andMe Announces Updated Safety and Preliminary Efficacy Data From the Phase 1/2a Study of 23ME-00610, an Investigational Antibody Targeting CD200R1
November 06, 2023
From
23andMe, Inc.
Via
GlobeNewswire
Tickers
ME
23andMe Launches Health Action Plan to Provide Personalized Recommendations Based on Genetic and Other Health Data
October 31, 2023
From
23andMe, Inc.
Via
GlobeNewswire
Tickers
ME
23andMe Announces Collaboration Extension with a New Data Licensing Agreement with GSK
October 30, 2023
From
23andMe, Inc.
Via
GlobeNewswire
Tickers
GSK
ME
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.